Mari Nakabayashi
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 5%
- Molecular Biology
- Oncology top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Philip W. KantoffWilliam OhWanling XieMark M. PomerantzMeredith M. ReganMary‐Ellen TaplinOliver SartorRobert W. Ross
- Topics
- Prostate Cancer Treatment and Research (32 papers)Prostate Cancer Diagnosis and Treatment (14 papers)Cancer, Lipids, and Metabolism (9 papers)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Mari Nakabayashi
40 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 82
- Pulmonary and Respiratory Medicine 914
- Cancer Research 455
- Molecular Biology 453
- Oncology 292
- Endocrinology, Diabetes and Metabolism 285
Countries citing papers authored by Mari Nakabayashi
This map shows the geographic impact of Mari Nakabayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mari Nakabayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mari Nakabayashi more than expected).
Fields of papers citing papers by Mari Nakabayashi
This network shows the impact of papers produced by Mari Nakabayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mari Nakabayashi. The network helps show where Mari Nakabayashi may publish in the future.
Co-authorship network of co-authors of Mari Nakabayashi
This figure shows the co-authorship network connecting the top 25 collaborators of Mari Nakabayashi. A scholar is included among the top collaborators of Mari Nakabayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mari Nakabayashi. Mari Nakabayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 73 | |
| 3 | 8 | |
| 4 | 15 | |
| 5 | 9 | |
| 6 | 62 | |
| 7 | 32 | |
| 8 | 15 | |
| 9 | 21 | |
| 10 | 15 | |
| 11 | 90 | |
| 12 | 36 | |
| 13 | 99 | |
| 14 | 13 | |
| 15 | 8 | |
| 16 | 36 | |
| 17 | 35 | |
| 18 | 8 | |
| 19 | 3 | |
| 20 | 49 |
About Mari Nakabayashi
Mari Nakabayashi is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Endocrinology, Diabetes and Metabolism, having authored 40 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Cancer, Lipids, and Metabolism (9 papers). The work is most often cited by research in Cancer Research (455 citations), Pulmonary and Respiratory Medicine (914 citations) and Endocrinology, Diabetes and Metabolism (285 citations). Mari Nakabayashi has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include Philip W. Kantoff, William Oh, Wanling Xie, Mark M. Pomerantz, Meredith M. Regan, Mary‐Ellen Taplin, Oliver Sartor, Robert W. Ross, Christopher J. Sweeney and Yasufumi Kaneda. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.